Literature DB >> 10702819

The FXIII Val34Leu polymorphism in venous and arterial thromboembolism.

J Corral1, R González-Conejero, J A Iniesta, J Rivera, C Martínez, V Vicente.   

Abstract

BACKGROUND AND
OBJECTIVE: Several hereditary disorders affecting coagulation factors have been identified as prothrombotic risk factors. Recently, the common Val34Leu polymorphism of the A-chain factor XIII gene, associated with high factor XIII activity, has been identified as a protective genetic factor against occlusive arterial and venous diseases in British and Finnish populations. The aim of our study was to investigate the role of this polymorphism in arterial and venous thromboembolic disorders in a distinct population. DESIGN AND METHODS: We analyzed the prevalence of this polymorphism in three case/control studies of consecutive patients from the south of Spain diagnosed as having acute coronary syndromes (101), acute cerebrovascular events (104), and deep venous thrombosis (97).
RESULTS: No significant differences were detected in the prevalence of genotypes or alleles between patients and controls. INTERPRETATION AND
CONCLUSIONS: The Leu 34 allele does not play an important role in the development of thromboembolic episodes in the Spanish population.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10702819

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  10 in total

1.  The impact of factor XIIIa V34L polymorphism on plasma factor XIII activity in the Chinese and Asian Indians from Singapore.

Authors:  Chew-Kiat Heng; Suman Lal; Nilmani Saha; Poh-Sim Low; M Ilyas Kamboh
Journal:  Hum Genet       Date:  2003-10-31       Impact factor: 4.132

2.  Factor XIII Val34Leu polymorphism and gamma-chain cross-linking at the site of microvascular injury in healthy and coumadin-treated subjects.

Authors:  A Undas; B Brzezinska-Kolarz; K Brummel-Ziedins; J Musial; A Szczeklik; K G Mann
Journal:  J Thromb Haemost       Date:  2005-09       Impact factor: 5.824

3.  Impact of FXIII-A Val34Leu polymorphism on coronary artery disease in Croatian patients.

Authors:  Ana Bronić; Goran Ferencak; Renata Zadro; Ana Stavljenić-Rukavina; Robert Bernat
Journal:  Mol Biol Rep       Date:  2007-09-27       Impact factor: 2.316

4.  Thrombophilic Gene Mutations in Relation to Different Manifestations of Venous Thromboembolism: A Single Tertiary Center Study.

Authors:  Tahir Bezgin; Cihangir Kaymaz; Özgür Akbal; Fatih Yılmaz; Hacer Ceren Tokgöz; Nihal Özdemir
Journal:  Clin Appl Thromb Hemost       Date:  2016-10-11       Impact factor: 2.389

5.  Coagulation Factor XIII Val34Leu Polymorphism in the Prediction of Premature Cardiovascular Events-The Results of Two Meta-Analyses.

Authors:  Beata Sarecka-Hujar; Danuta Łoboda; Elżbieta Paradowska-Nowakowska; Krzysztof S Gołba
Journal:  J Clin Med       Date:  2022-06-15       Impact factor: 4.964

Review 6.  The role of genetic risk factors in arterial ischemic stroke in pediatric and adult patients: a critical review.

Authors:  Ilona Kopyta; Beata Sarecka-Hujar; Joanna Sordyl; Ryszard Sordyl
Journal:  Mol Biol Rep       Date:  2014-03-01       Impact factor: 2.316

7.  Correlation with Platelet Parameters and Genetic Markers of Thrombophilia Panel (Factor II g.20210G>A, Factor V Leiden, MTHFR (C677T, A1298C), PAI-1, β-Fibrinogen, Factor XIIIA (V34L), Glycoprotein IIIa (L33P)) in Ischemic Strokes.

Authors:  Sener Tasdemir; Haktan Bagis Erdem; Ibrahim Sahin; Lutfi Ozel; Gokhan Ozdemir; Recep Eroz; Abdulgani Tatar
Journal:  Neuromolecular Med       Date:  2016-03-07       Impact factor: 3.843

8.  Factor XIII gene V34L mutation in the Lebanese population: another unique feature in this community?

Authors:  Rami A R Mahfouz; Amira S Sabbagh; Dina M R Shammaa; Zaher K Otrock; Ghazi S Zaatari; Ali T Taher
Journal:  Mol Biol Rep       Date:  2007-05-22       Impact factor: 2.316

9.  Update on the Serum Biomarkers and Genetic Factors Associated with Safety and Efficacy of rt-PA Treatment in Acute Stroke Patients.

Authors:  C Nafría; I Fernández-Cadenas; M Mendioroz; S Domingues-Montanari; M Hernández-Guillamón; J Fernández-Morales; A Del Río-Espínola; D Giralt; L Deu; P Delgado; A Rosell; J Montaner
Journal:  Stroke Res Treat       Date:  2011-06-09

10.  Molecular Analysis of Prothrombotic Gene Variants in Venous Thrombosis: A Potential Role for Sex and Thrombotic Localization.

Authors:  Gustavo Cernera; Alessandro Di Minno; Felice Amato; Ausilia Elce; Renato Liguori; Dario Bruzzese; Antonella Miriam Di Lullo; Giuseppe Castaldo; Federica Zarrilli; Marika Comegna
Journal:  J Clin Med       Date:  2020-04-02       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.